600521 华海药业
2026/03 - 三个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额398,6331,230,0892,172,6642,217,0211,242,693
投资活动产生之现金流量净额(576,719)(1,867,554)(1,920,276)(1,622,771)(2,432,575)
筹资活动产生之现金流量净额624,645617,070(132,912)(644,232)609,043
汇率变动对现金及现金等价物的影响(47,291)(10,651)51,15828,99854,654
现金及现金等价物净增加/(减少)399,268(31,046)170,634(20,984)(526,185)
期初现金及现金等价物余额1,446,5541,477,6001,306,9661,327,9501,854,135
期末现金及现金等价物余额1,845,8231,446,5541,477,6001,306,9661,327,950